BROXYDEX COUGH

This brand name is authorized in Nigeria.

Active ingredients

The drug BROXYDEX COUGH contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII YC2ZOM3Z8V - BROMHEXINE HYDROCHLORIDE
 

Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”.

 
Read more about Bromhexine
2
UNII 7355X3ROTS - DEXTROMETHORPHAN
 

Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors.

 
Read more about Demorphan
3
UNII 01Q9PC255D - AMMONIUM CHLORIDE
 
Read more about Ammonium chloride

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-6011 Syrup Broxydex Cough Syrup SYRUP 8 mg/5 mL; 10 mg/5 mL; 100 mg/5 mL 100 mL Each 5 mL syrup contains: Bromhexine Hydrochloride 8 mg, Dextromethorphan Hydrobromide 10 mg, Ammonium Chloride 100 mg 26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05FB02 Cough suppressants and expectorants R Respiratory system → R05 Cough and cold preparations → R05F Cough suppressants and expectorants, combinations → R05FB Other cough suppressants and expectorants
Discover more medicines within R05FB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-6011

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.